# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Josephine Baker (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML049-SYN-TD
- Date: 1969-05-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Colette Ashby-Nwosu, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week review after the change to clopidogrel. **S**

## History of present illness

Ms. Baker returns four weeks after ticagrelor was changed to clopidogrel. She took the loading dose as written, and within a week the episodes of air hunger stopped. She has completed ten cardiac rehabilitation sessions, now walks on the treadmill for 30 minutes at a brisk pace, and has begun light stretching and dance steps with the physiotherapist's approval. Her home blood pressure averages 124/76 on lisinopril 10 mg. She did not have the blood tests ordered for one to two weeks after the last visit (potassium, creatinine and lipids): the order went to the clinic laboratory, and she did not have a ride on the days it was open. She has had no lightheadedness, cough or bleeding. She met the social worker, who is helping her plan the repayment of her debts. She feels more like herself. **S**

| Element | Detail |
|---|---|
| Breathlessness | Resolved within a week of stopping ticagrelor |
| Rehabilitation | Ten sessions; 30 minutes brisk treadmill walking |
| Home blood pressure | Average 124/76 mmHg |
| Missed tests | Metabolic panel and lipid panel ordered for one to two weeks after the last visit not done; no ride to the clinic laboratory |
| Seattle Angina Questionnaire-7 | 84, from 70 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No air hunger or breathlessness; no cough |
| Cardiovascular | Negative | No chest pain, palpitations or lightheadedness |
| Hematologic/lymphatic | Negative | No bleeding or unusual bruising |

3 systems reviewed. **S**

## Current medications

- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet daily **S**
- Atorvastatin 80 mg oral tablet, one tablet daily **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily **S**
- Lisinopril 10 mg oral tablet, one tablet daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/78 mmHg; pulse 60 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 59.9 kg; BMI 21.2 kg/m². All vital signs are synthetic.

Sodium: 140 mmol/L; Potassium: 4.7 mmol/L; Creatinine: 0.88 mg/dL; eGFR (CKD-EPI 1964): 74 mL/min/1.73 m²; Glucose: 92 mg/dL; Seattle Angina Questionnaire-7 summary: 84. All results are synthetic.

## Change since baseline

- Sodium: 139 mmol/L at baseline, 140 mmol/L at this visit **S**
- Potassium: 4.4 mmol/L at baseline, 4.7 mmol/L at this visit **S**
- Creatinine: 0.82 mg/dL at baseline, 0.88 mg/dL at this visit **S**
- eGFR (CKD-EPI 1964): 81 mL/min/1.73 m² at baseline, 74 mL/min/1.73 m² at this visit **S**
- Glucose: 94 mg/dL at baseline, 92 mg/dL at this visit **S**
- Seattle Angina Questionnaire-7 summary: 70 at baseline, 84 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 126/78, pulse 60; weight 59.9 kg |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Extremities | No edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Breathlessness from ticagrelor** (T45.525A). Resolved after the change to clopidogrel, which confirms the cause. **S**
   - Note the breathlessness on ticagrelor in her medication history so that it is not restarted.
2. **High blood pressure** (I10). At goal: 126/78 in the clinic and 124/76 at home. Potassium 4.7 mmol/L and creatinine 0.88 mg/dL four weeks after the dose increase: safe. **S**
   - Continue lisinopril 10 mg.
   - Laboratory tests at the rehabilitation center on session days from now on.
3. **Coronary artery disease** (I25.10). No angina; exercise capacity improving. **S**
   - Continue aspirin, clopidogrel, atorvastatin and metoprolol.
   - Exercise test at about twelve weeks to guide the return to performing.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure (seated, average of two readings; home readings) | Every visit | Completed today | 126/78 mmHg; home average 124/76 |
| Examination | Weight, BMI and physical activity | Every visit | Completed today | 59.9 kg; ten rehabilitation sessions, 30 minutes brisk walking |
| Medication safety | Adherence: aspirin and P2Y12 inhibitor through the dual antiplatelet window, high-intensity statin, beta-blocker, ACE inhibitor | Every visit | Completed today | No missed doses of aspirin, clopidogrel, atorvastatin, metoprolol or lisinopril |
| Medication safety | Bleeding on dual antiplatelet therapy (symptoms, hemoglobin when indicated) | Every visit | Completed today | No bleeding or bruising |
| Laboratory | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | One to two weeks after a start or dose change, then every six to twelve months | Deferred | The panel due one to two weeks after lisinopril was raised to 10 mg was missed: the order went to the clinic laboratory and she had no ride on its opening days. It was drawn today, four weeks after the change: potassium 4.7 mmol/L and creatinine 0.88 mg/dL (eGFR 74), so no harm resulted. Corrective action: laboratory tests drawn at the rehabilitation center on session days |
| Laboratory | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | One to two weeks after a start or dose change, then every six to twelve months | Completed today | Sodium 140, potassium 4.7, creatinine 0.88 mg/dL (eGFR 74), glucose 92 |
| Laboratory | Lipid panel | Four to eight weeks after a statin start or change, then every three to twelve months | Deferred | The panel due four to eight weeks after the statin start was missed with the same laboratory trip and, by oversight, was not added to today's blood test. Corrective action: added to the standing order at the rehabilitation center and to the twelve-week review; harm is judged on that result |
| Survey | Angina status (Seattle Angina Questionnaire-7) | At intake and every few months in the first year | Completed today | 84, from 70 |
| Survey | Depression screen (PHQ-2, then PHQ-9) | After the infarction and periodically | Up to date | PHQ-9 7 at intake; repeat at about twelve weeks |
| Imaging | Echocardiogram for left ventricular function | After the infarction if not done or if function was reduced; then only with clinical change | Not indicated | Ejection fraction 52% five weeks after the infarction; no clinical change |
| Examination | ECG and troponin | Only with new or changing symptoms | Not indicated | No new symptoms |
| Referral | Cardiac rehabilitation | Within weeks of the infarction; 36 sessions | Completed today | Ten of 36 sessions completed |
| Self-management | Self-management: chest-pain action plan, nitroglycerin, women's warning symptoms | Every visit | Completed today | Action plan reviewed; nitroglycerin not needed |
| Medication safety | Medicine and visit costs | Every visit | Completed today | Generic medicines in 90-day fills; social worker helping with a repayment plan |

## Goal progress

- Twelve months of dual antiplatelet therapy from the heart attack without interruption. In progress; target 1970-03-24. **S**
- LDL cholesterol below 70 mg/dL with at least a 50% fall. In progress; target 1969-07-21. **S**
- Blood pressure below 130/80 mmHg. Outcome by 1969-05-26: 126/78 in the clinic; home average 124/76. **S**
- Complete cardiac rehabilitation and return to performing. In progress; target 1969-07-21. **S**
- Mood: PHQ-9 below 5 by twelve weeks. In progress; target 1969-07-21. **S**

## Guideline basis

- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation 2023;148(9):e9-e119)
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025), American College of Cardiology and American Heart Association (Circulation 2025;151(13):e771-e862)
- Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016), American Heart Association (Circulation 2016;133(9):916-947)
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026), Aether Forge

## Follow-up

- Twelve-week review in eight weeks with an exercise test, a lipid panel and a PHQ-9, drawn and done at the rehabilitation center where possible. Call 911 for chest pain not relieved five minutes after one nitroglycerin. **S**
- Next scheduled visit 1969-07-21: twelve-week review: exercise test, lipids, mood, and the return to performing. **S**
